Discovery of novel leads as dual acting inhibitors of acetylcholinesterase using pharmacophore modeling, docking consensus and 3D-QSAR studies for Alzheimer?s disease
which is believed to be due to its rapid hydrolysis of acetylcholine in the synaptic clefts by acetylcholinesterase (AChE).The limited number of drugs available for the treatment

